A service of StreetInsider.com
Welcome

Most Popular

AAPL 89.34
GOOG 266.85
RIMM 36.60
MSFT 18.70
C 6.83

Recently Added

CMVT 5.90
OWC 0.00
GRA 3.48
KWR 11.22
FAS 17.27

Gaining Speed

FAZ 78.00
MGG 12.50
OVEN 3.51
CRTXD 3.47
CMVT 5.90
5.26 +0.07 (1.32%) VVUS

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:5.26 Change:+0.07 (1.32%) Prev Close:5.19 Open: 5.29 Days Range:5.20 – 5.60 52 Week Range: 4.28 - 9.27 Volume:666084 P/E: 43.83
EPS:0.12

Member Comments

No member comments available for VVUS


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 12/02/08

Recent Alert on 11/26/08 at 10:39am
Credit Suisse Starts Vivus (VVUS) at Neutral

Credit Suisse initiates coverage on Vivus (Nasdaq: VVUS) with a Neutral rating. VIVUS, Inc., a pharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States.

Recent Alert on 11/04/08 at 4:00pm
Vivus (VVUS) Reports Breakeven Q3 Earnings
Recent Alert on 10/06/08 at 12:50pm
VIVUS (VVUS) Announces the Weight Loss Effects of Qnexa in Type 2 Diabetes
Recent Alert on 09/03/08 at 3:53pm
VIVUS (VVUS) CEO Unloads 50K Shares As Stock Nears Highs

View AllRecent Press Releases

Press Release on 12/02/08 at 7:00am
VIVUS to Present at J.P. Morgan 2008 SMid Cap Conference

View AllRecent SEC Filings

SEC Filing on 12/01/08 at 5:14pm
Form 4 VIVUS INC For: Nov 30 Filed by: Changjin Wang

View AllRecent Blog Posts

Blog Posts on 08/04/08 at 8:16pm
VIVUS Inc. Q2 2008 Earnings Call Transcript
Blog Posts on 06/05/08 at 1:48am
Analyst Notes: Lilly Gets A Lift, Pfizer Goes Pfft
Blog Posts on 05/30/08 at 11:56am
VIVUS Inc. Q1 2008 Earnings Call Transcript
Blog Posts on 05/29/08 at 5:00pm
Analyst downgrades: SNDA, ESLR, SPWR and MAR